Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma
Moh’d Khushman(Sylvester Comprehensive Cancer Center), Naomi Dempsey(Sylvester Comprehensive Cancer Center), Jennifer Cudris Maldonado(Pontificia Universidad Javeriana), Arturo Loaiza‐Bonilla(University of Pennsylvania), Michel Velez(Memorial Healthcare System), Lauren Carcas(Florida Cancer Care), Daniel Dammrich(University of Miami), Jorge Hurtado-Cordovi(Sylvester Comprehensive Cancer Center), Ritesh Parajuli(University of Miami), Terri Pollack(University of Miami), Ana Paula P. Harwood(Sylvester Comprehensive Cancer Center), Jessica MacIntyre(University of Miami), Ching‐Wei D. Tzeng(Markey Cancer Center), Jaime R. Merchan(Sylvester Comprehensive Cancer Center), María H. Restrepo(University of Miami), Ikechukwu Immanuel Akunyili(Sylvester Comprehensive Cancer Center), Afonso Ribeiro(Sylvester Comprehensive Cancer Center), Govindarajan Narayanan(University of Miami), Lorraine Portelance(University of Miami), Danny Sleeman(University of Miami), Joé U. Levi(University of Miami), Caio M.S. Rocha Lima(Sylvester Comprehensive Cancer Center), Peter J. Hosein(University of Kentucky)
Cited by 81
Abstract
Related Papers
No related papers found
Powered by citation graph analysis